Triple-Negative Breast Cancer Panel 3 (ATCC® TCP-1003)

Organism: Homo sapiens, human  / 

Permits and Restrictions

View Permits

Organism Homo sapiens, human
HCC1599, ATCC CRL-2331
HCC1937, ATCC CRL-2336
HCC1143, ATCC CRL-2321
MDA-MB-468, ATCC HTB-132
HCC38, ATCC CRL-2314
HCC70, ATCC CRL-2315
HCC1806, ATCC CRL-2335
HCC1187, ATCC CRL-2322
DU4475, ATCC HTB-123
BT-549, ATCC HTB-122
Hs 578T, ATCC HTB-126
MDA-MB-436, ATCC HTB-130
MDA-MB-453, ATCC HTB-131
BT-20, ATCC HTB-19
HCC1395, ATCC CRL-2324
Biological understanding of top genetic alterations across tumor types
Validation and characterization of potential cancer driver genes
Functional profiling and molecular profiling of subtype-specific cancer cell lines
Testing small molecules or biologics for cancer drug development
Type Strain no
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

A panel of 17 triple-negative breast tumor cell lines sharing a mesenchymal-like or luminal morphology. See J Clinical Inv (2011) 121(7):2750-2767 for more information.
Product Format frozen
Storage Conditions LN vapor (less than -130°C) only
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation